-
101
Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth.
منشور في 2025الموضوعات: -
102
-
103
-
104
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
منشور في 2025الموضوعات: -
105
-
106
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
منشور في 2025الموضوعات: -
107
General information of patient who diagnosis insomnia disorder (N = 518,119).
منشور في 2025الموضوعات: -
108
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
منشور في 2025الموضوعات: -
109
-
110
Self-reported affect change during CFI for participants who attended multiple sessions (N = 22).
منشور في 2023الموضوعات: -
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120